| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10091654 | The Journal of Pediatrics | 2005 | 4 Pages |
Abstract
Patients in the Stroke Prevention Trial for Sickle Cell Anemia Study who received CTX had improved height and weight and BMI over a 2-year period. Higher hemoglobin levels resulting from transfusion may improve growth by lowering energy expenditure. In addition to the prevention of vasoocclusive events, CTX results in significant improvement in the growth of children with sickle cell disease.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Perinatology, Pediatrics and Child Health
Authors
Winfred C. MD, Knashawn H. ScD, Charles D. MD, Lori MD, Nancy MD, Robert MD, Don PhD, for the STOP Investigators for the STOP Investigators,